The COVID-19 vaccine, developed by the Vector Research Center in Russia, will be ready for mass production in late 2020 or early 2021.
This was stated by the head of the center's laboratory Ilnaz Imatdinov in an interview with Russia 24. According to him, the drug will be useful for people with the disease. Because COVID-19 antibodies remain in the body for only a few months.